ENTRY       D06552                      Drug
NAME        Alcaftadine (JAN/USAN/INN);
            Lastacaft (TN)
PRODUCT     LASTACAFT (Allergan)
FORMULA     C19H21N3O
EXACT_MASS  307.1685
MOL_WEIGHT  307.3895
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
REMARK      ATC code: S01GX11
            Product: D06552<US>
EFFICACY    Antiallergic, Anti-inflammatory, H1 receptor antagonist
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04080(3269)  Neuroactive ligand-receptor interaction
            hsa04750(3269)  Inflammatory mediator regulation of TRP channels
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01G DECONGESTANTS AND ANTIALLERGICS
                S01GX Other antiallergics
                 S01GX11 Alcaftadine
                  D06552  Alcaftadine (JAN/USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Anti-Allergy Agents
               Antihistamine and Mast Cell Stabilizer
                Alcaftadine
                 D06552  Alcaftadine (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                D06552  Alcaftadine
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D06552  Alcaftadine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D06552  Alcaftadine (JAN/USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06552
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06552
            Rx-to-OTC switch list in the USA [br08315.html]
             D06552
DBLINKS     CAS: 147084-10-4
            PubChem: 47208208
            ChEBI: 71023
            LigandBox: D06552
ATOM        23
            1   C1x C    31.5634  -17.2994
            2   C8y C    30.7213  -16.1898
            3   C8y C    31.0565  -14.8330
            4   C2y C    32.3175  -14.2549
            5   C1x C    32.9692  -17.3246
            6   C8y C    33.5711  -14.8772
            7   N4y N    33.8576  -16.2459
            8   C8x C    30.0494  -13.8646
            9   C8x C    28.7074  -14.2527
            10  C8x C    28.3722  -15.6095
            11  C8x C    29.3793  -16.5776
            12  C8y C    35.2479  -16.3964
            13  C8x C    35.8206  -15.1206
            14  N5x N    34.7843  -14.1818
            15  C2y C    32.3392  -12.8800
            16  C1x C    33.6332  -12.1989
            17  C1x C    33.5852  -10.7991
            18  N1y N    32.3840  -10.0800
            19  C1x C    31.1601  -10.7611
            20  C1x C    31.1380  -12.1610
            21  C1a C    32.4061   -8.6800
            22  C4a C    35.9448  -17.6121
            23  O4a O    37.3448  -17.6121
BOND        26
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     3   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    2  11 2
            13    7  12 1
            14   12  13 2
            15   13  14 1
            16    6  14 2
            17    4  15 2
            18   15  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   15  20 1
            24   18  21 1
            25   12  22 1
            26   22  23 2
///
